science is motivated by the need to provide effective treatments
to the right patients at the right doses for a specific disease
indication). The term is used mostly in the health sciences and refers to
real-time translation of bench science, conducted
in a lab, to bedside clinical practice or dissemination
population-based community interventions.
Source: NIH -- Read more
Academic Breast Cancer
Henry G. Kaplan, M.D.
Institute, Seattle WA
Dr. Henry "Hank" Kaplan, MD, is the Chief of Medical
Oncology and Chief of the Medical Oncology Breast Service at Swedish.
Dr. Kaplan went to Medical
School at the University of Rochester, NY. Did his Residency at the
University of Washington, WA and a Fellowship with the National Cancer
Institute/National Institutes of Health. Previously he was Chief
Resident, Dept of Medicine: University of Washington, WA; Clinical
Associate Professor, University of Washington; Clinical Professor of
Medicine Brown University 1977-79; Adjunct Professor of Pharmacy,
University of Rhode Island 1977-79; and Assistant Professor of Medicine,
University of Washington 1979-1981. His Board Certifications include
Internal Medicine and Oncology.
The primary focus of Dr. Kaplan’s research continues to be on breast
cancer, although he is also continuing his work in hematological
malignancies – cancers affecting blood, bone marrow and lymph nodes –
and, more recently, in the area of targeted therapy for genomic mutation.
Dr. Henry Kaplan is the lead investigator for the several clinical trials
currently at the Swedish Cancer Institute:
He has received multiple faculty teaching awards and a Swedish Physician
Recognition Award, AOA. He was recognized in Seattle Metropolitan
magazine’s annual Top Doctors and Nurse Practitioners feature as top doc
every year since 2006. Dr. Kaplan was also voted "Top
Doctors" in Seattle Magazine (2013, 2014) based on peer surveys from
physicians in King, Pierce, Snohomish and Kitsap counties in Washington.
About Swedish Cancer
As a Seattle-area leader in diagnosis, treatment and recovery since
1932, the Swedish Cancer Institute (SCI) cancer care network offers
services to help you fight cancer—and win. Our team includes a host of
oncologists—doctors focused exclusively on the care and treatment of
cancer, using medication, radiation and other therapies. At our locations
in and around the greater Seattle area, we work in a collaborative,
multidisciplinary environment that focuses on the patient—not the
disease. And even though we use some of the most advanced technologies
and procedures, we also offer a wide range of complementary treatments
and services that address your psychological, emotional and spiritual
needs. The Swedish Cancer Institute has a new weapon in the fight against
cancer. It's called personalized medicine -- the biggest news in cancer
treatment in years. Learn more at http://www.swedish.org/services/cancer-institute